[ad_1]
Burberry shares sank on Monday after the U.K. luxury fashion group said it’s chief executive officer will be replaced, following a profit warning and suspension of its 2025 dividend.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...